Sigurdur Olafsson
Angel investor in New Jersey
New Jersey
Sigurdur Olafsson, Angel investor in New Jersey is an active investor based in New Jersey. This profile covers what Sigurdur Olafsson backs, at which stage, and how founders can reach out in 2026.
Mr. Sigurdur O. Olafsson has been President, Chief Executive Officer and a director since June 2022. He is a serves as President & Chief Executive Officer at Keenova. He is an Angel Indivisual. Mr. Olafsson has almost 30 years of diverse pharmaceutical experience across branded and generic drugs. Before joining Mallinckrodt, Mr. Olafsson served as chief executive officer of Hikma Pharmaceuticals plc from February 2018 to June 2022. Prior to Hikma, Mr. Olafsson served as president and chief executive officer of the Global Generic Medicines Group of Teva Pharmaceuticals, from July 2014 to January 2017. Before that, he was president of Actavis plc (Watson) (from September 2010 to June 2014) and president and chief executive officer of the Actavis Group (from October 2003 to August 2010), which develop, manufacture and distribute branded, generic and biosimilar products. Mr. Olafsson has also held a number of leadership positions in Pfizer's Global R&D organization in the U.K. and U.S., focused on branded drug development, and served as head of drug development for Omega Farma in Iceland. Mr. Olafsson has previously served as a director on the boards of Hikma (from 2018 to 2022) and Pfenex Inc. (from 2017 to 2019). Mr. Olafsson holds a MS in pharmacy (Cand Pharm) from the University of Iceland, Reykjavik.
- Investor type
- Angel
- Stages
- Early Stage Venture
- Invests in
- Healthcare & BiotechBiotech & Pharma
- Location
- New Jersey
- Typical check
- $500K
- Past investments
- 2
Notable investments
SmittenPfenex IncHow to reach Sigurdur Olafsson
Angels and operators like Sigurdur Olafsson reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Reach active investors like this one
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Sigurdur Olafsson." Round Funded investor database, updated September 8, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/investor/sigurdur-olafsson-491286-4
Frequently Asked Questions
What does Sigurdur Olafsson invest in?
Sigurdur Olafsson invests in Healthcare & Biotech and Biotech & Pharma, typically at Early Stage Venture. Match your sector and stage, then reach out with a personalized pitch.
What stage does Sigurdur Olafsson invest at?
Sigurdur Olafsson typically invests at Early Stage Venture. Lead with traction that fits the stage when you reach out.
What is Sigurdur Olafsson's typical check size?
Sigurdur Olafsson typically writes checks around $500K. Use it as a signal for whether your raise fits their stage.
How do founders reach investors like this?
Round Funded lists active investors with verified, professional contact details for signed-up founders. Filter by sector, stage and location, then send a personalized pitch from your own inbox.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.